FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1968658875> ?p ?o ?g. }

• W1968658875 endingPage "206" @default.
• W1968658875 startingPage "200" @default.
• W1968658875 abstract "SUMMARY We and others have shown that several T cell responses induced by the mitogen phytohaemagglutinin (PHA), including T cell colony formation, IL-2 receptor (IL-2R) expression, and IL-2 production are impaired in patients with AIDS and lymphadenopathy syndrome (LAS). We investigated whether phorbol myristate acetate (PMA) could act in synergy with PHA (as it does in healthy subjects) to enhance in vitro T cell responses of patients at all stages of infection by HIV. In AIDS patients with opportunistic infections (AIDS/OI), PHA + IL-2 + PMA led to a total disappearance of T cell colonies in 10/11 patients, among whom six already displayed very low numbers of colonies induced by PHA + IL-2 (less than 50 colonies/5 × 104 cells). In contrast, T cell colony formation induced by PHA + IL-2 + PMA was maintained or increased, compared with that induced by PHA + IL-2, in five out of six AIDS patients with Kaposi's sarcoma (AIDS/KS), 10/14 LAS and six out of seven HIV-seropositive asymptomatic (HIV+/AS) homosexuals. In these three groups of patients, a low percentage of colony cells induced by PHA + IL-2 + PMA expressed CD3 and CD4 molecules, but 50-89% of cells were IL-2R (Tac) positive, as in healthy controls. Studies on T cell activation and IL-2 production were performed on a selected group of 12 HIV-infected patients for whom sufficient numbers of lymphocytes could be obtained. PMA induced CD4 down-modulation in controls and in HIV-infccted patients. However. CD3 down-modulation and induction of the Tac chain of IL-2R by PMA were significantly impaired in patients, compared with controls, and these two parameters were correlated. Although PHA alone induced virtually normal levels of Tac antigen on patients’ cells, Tac induction by PHA + PMA was significantly decreased in patients versus controls. Cells from five out of 10 patients tested failed to produce detectable amounts of IL-2 after PHA stimulation, whereas IL-2 production increased significantly in all patients tested (n = 9) after PH A + PMA, with a level of IL-2 activity significantly higher than in controls. No correlation was found in this group of patients between the effects of PMA + PHA on T cell colony formation, Tac expression, or IL-2 production, as compared with PHA alone. Taken together, our results indicate that in vitro T cell functional studies with PMA may be useful to evaluate better the defects of T cell activation in HIV-infected patients." @default.
• W1968658875 created "2016-06-24" @default.
• W1968658875 creator A5012824484 @default.
• W1968658875 creator A5020457281 @default.
• W1968658875 creator A5048522420 @default.
• W1968658875 creator A5050082821 @default.
• W1968658875 creator A5072090307 @default.
• W1968658875 creator A5077410158 @default.
• W1968658875 creator A5083623881 @default.
• W1968658875 creator A5089029634 @default.
• W1968658875 date "1990-08-01" @default.
• W1968658875 modified "2023-10-18" @default.
• W1968658875 title "Effect of phorbol myristate acetate on T cell colony formation, interleukin-2 (IL-2) receptor expression and IL-2 production by cells from patients at all stages of HIV infection" @default.
• W1968658875 cites W1480361432 @default.
• W1968658875 cites W1506157243 @default.
• W1968658875 cites W1513452110 @default.
• W1968658875 cites W1539646282 @default.
• W1968658875 cites W1539876235 @default.
• W1968658875 cites W1541233718 @default.
• W1968658875 cites W1581164772 @default.
• W1968658875 cites W177971367 @default.
• W1968658875 cites W1910684728 @default.
• W1968658875 cites W1963514686 @default.
• W1968658875 cites W1968112603 @default.
• W1968658875 cites W1977282539 @default.
• W1968658875 cites W1981164507 @default.
• W1968658875 cites W1983882468 @default.
• W1968658875 cites W1986357635 @default.
• W1968658875 cites W1996593919 @default.
• W1968658875 cites W1999881560 @default.
• W1968658875 cites W2001692359 @default.
• W1968658875 cites W2004180659 @default.
• W1968658875 cites W2027550436 @default.
• W1968658875 cites W2028692741 @default.
• W1968658875 cites W2031788467 @default.
• W1968658875 cites W2060613726 @default.
• W1968658875 cites W2077060921 @default.
• W1968658875 cites W2113282092 @default.
• W1968658875 cites W2127036529 @default.
• W1968658875 cites W2129001976 @default.
• W1968658875 cites W2151251642 @default.
• W1968658875 cites W216755571 @default.
• W1968658875 cites W22117694 @default.
• W1968658875 cites W2266777675 @default.
• W1968658875 cites W2277548375 @default.
• W1968658875 cites W2294121480 @default.
• W1968658875 cites W2399088342 @default.
• W1968658875 cites W2401208479 @default.
• W1968658875 cites W2403676576 @default.
• W1968658875 cites W2405333006 @default.
• W1968658875 cites W2409528426 @default.
• W1968658875 cites W2443203482 @default.
• W1968658875 doi "https://doi.org/10.1111/j.1365-2249.1990.tb03318.x" @default.
• W1968658875 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1535056" @default.
• W1968658875 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1696861" @default.
• W1968658875 hasPublicationYear "1990" @default.
• W1968658875 type Work @default.
• W1968658875 sameAs 1968658875 @default.
• W1968658875 citedByCount "6" @default.
• W1968658875 countsByYear W19686588752021 @default.
• W1968658875 crossrefType "journal-article" @default.
• W1968658875 hasAuthorship W1968658875A5012824484 @default.
• W1968658875 hasAuthorship W1968658875A5020457281 @default.
• W1968658875 hasAuthorship W1968658875A5048522420 @default.
• W1968658875 hasAuthorship W1968658875A5050082821 @default.
• W1968658875 hasAuthorship W1968658875A5072090307 @default.
• W1968658875 hasAuthorship W1968658875A5077410158 @default.
• W1968658875 hasAuthorship W1968658875A5083623881 @default.
• W1968658875 hasAuthorship W1968658875A5089029634 @default.
• W1968658875 hasBestOaLocation W19686588751 @default.
• W1968658875 hasConcept C114684123 @default.
• W1968658875 hasConcept C167672396 @default.
• W1968658875 hasConcept C170493617 @default.
• W1968658875 hasConcept C195794163 @default.
• W1968658875 hasConcept C203014093 @default.
• W1968658875 hasConcept C2776090121 @default.
• W1968658875 hasConcept C2777371288 @default.
• W1968658875 hasConcept C2777761686 @default.
• W1968658875 hasConcept C2778690821 @default.
• W1968658875 hasConcept C2780043322 @default.
• W1968658875 hasConcept C2780050583 @default.
• W1968658875 hasConcept C2992881475 @default.
• W1968658875 hasConcept C2993002077 @default.
• W1968658875 hasConcept C55493867 @default.
• W1968658875 hasConcept C62478195 @default.
• W1968658875 hasConcept C86803240 @default.
• W1968658875 hasConcept C8891405 @default.
• W1968658875 hasConceptScore W1968658875C114684123 @default.
• W1968658875 hasConceptScore W1968658875C167672396 @default.
• W1968658875 hasConceptScore W1968658875C170493617 @default.
• W1968658875 hasConceptScore W1968658875C195794163 @default.
• W1968658875 hasConceptScore W1968658875C203014093 @default.
• W1968658875 hasConceptScore W1968658875C2776090121 @default.
• W1968658875 hasConceptScore W1968658875C2777371288 @default.
• W1968658875 hasConceptScore W1968658875C2777761686 @default.
• W1968658875 hasConceptScore W1968658875C2778690821 @default.
• W1968658875 hasConceptScore W1968658875C2780043322 @default.
• W1968658875 hasConceptScore W1968658875C2780050583 @default.

• next